Literature DB >> 8473659

Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging.

J Katz1, J Whang, L M Boxt, R J Barst.   

Abstract

OBJECTIVES: This study was designed to test the accuracy of nuclear magnetic resonance (NMR) imaging as a noninvasive technique for estimating right ventricular mass in normal subjects and in patients with primary pulmonary hypertension.
BACKGROUND: An accurate means of noninvasively estimating right ventricular mass may allow better characterization of the degree of right-sided pressure or volume overload caused by underlying cardiac or pulmonary diseases.
METHODS: End-diastolic short-axis electrocardiogram (ECG)-gated spin echo NMR images of the heart were obtained in vivo in 13 patients with primary pulmonary hypertension and 10 normal adult volunteers. Both right and left ventricular mass were computed by summing the myocardial slice volumes over all slices spanning the myocardium and multiplying by myocardial density. This technique of myocardial mass determination was verified by imaging 10 calf hearts and comparing the NMR-determined right and left myocardial mass with the actual mass determined by weighing the right and left ventricles.
RESULTS: In the calf heart study, an excellent correlation was obtained between the directly measured ventricular mass and the NMR-calculated mass, for both the right and the left ventricle. Patients with primary pulmonary hypertension had an elevated right ventricular mass index compared with that of normal subjects (62.69 +/- 8.72 g/m2 vs. 23.32 +/- 1.36 g/m2, p < 0.0005). There was no significant difference in left ventricular mass index between the two groups. Both mean intraobserver and inter-observer variability in myocardial mass determination were low. Linear regression analysis between right ventricular mass index and mean pulmonary artery pressure was significant (r = 0.75, p < 0.003).
CONCLUSIONS: Electrocardiogram-gated spin echo NMR imaging of the heart may be used for quantitating right ventricular mass in normal subjects and in patients with primary pulmonary hypertension, in whom it may also provide an alternative noninvasive technique for estimating mean pulmonary artery pressure.

Entities:  

Mesh:

Year:  1993        PMID: 8473659     DOI: 10.1016/0735-1097(93)90327-w

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  29 in total

1.  MRI-derived left ventricular function parameters and mass in healthy young adults: relation with gender and body size.

Authors:  J T Marcus; L K DeWaal; M J Götte; R J van der Geest; R M Heethaar; A C Van Rossum
Journal:  Int J Card Imaging       Date:  1999-10

Review 2.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

3.  Reliable 5-min real-time MR technique for left-ventricular-wall motion analysis.

Authors:  Marcus Katoh; Harald P Kühl; Elmar Spuentrup; Claudia S A Lipke; Rolf W Günther; Arno Buecker
Journal:  Eur Radiol       Date:  2007-01-12       Impact factor: 5.315

Review 4.  Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.

Authors:  Jennifer L Snow; Steven M Kawut
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

Review 5.  Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.

Authors:  Theodoros Dimitroulas; Sophie Mavrogeni; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2012-02-07       Impact factor: 20.543

6.  The importance of trabecular hypertrophy in right ventricular adaptation to chronic pressure overload.

Authors:  Mariëlle C van de Veerdonk; Sophie A Dusoswa; J Tim Marcus; Harm-Jan Bogaard; Onno Spruijt; Taco Kind; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-04       Impact factor: 2.357

Review 7.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

8.  Small organs with a high metabolic rate explain lower resting energy expenditure in African American than in white adults.

Authors:  Dympna Gallagher; Jeanine Albu; Qing He; Stanley Heshka; Lawrence Boxt; Norman Krasnow; Marinos Elia
Journal:  Am J Clin Nutr       Date:  2006-05       Impact factor: 7.045

9.  Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension.

Authors:  Catherine E Simpson; Rachel L Damico; Todd M Kolb; Stephen C Mathai; Rubina M Khair; Takahiro Sato; Khalil Bourji; Ryan J Tedford; Stefan L Zimmerman; Paul M Hassoun
Journal:  Eur Respir J       Date:  2019-04-04       Impact factor: 16.671

10.  Cardiac magnetic resonance-derived right ventricular outflow tract systolic flow acceleration: a novel index of right ventricular function and prognosis in patients with pulmonary arterial hypertension.

Authors:  Ki-Woon Kang; Hyuk-Jae Chang; Yeon Pyo Yoo; Hyeon Soo Yoon; Young-Jin Kim; Byoung-Wook Choi; Chi-Young Shim; Jongwon Ha; Namsik Chung
Journal:  Int J Cardiovasc Imaging       Date:  2013-07-17       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.